About Oral Cancer Foundation News Team - A

This author has not yet filled in any details.
So far Oral Cancer Foundation News Team - A has created 2444 blog entries.

Blood filter to be tested on cancer patients

Source: www.signonsandiego.com Author: Keith Darcé A Santa Monica research center will test an experimental therapeutic filtering device being developed by Aethlon Medical on blood taken from cancer patients, the San Diego company said Wednesday. The study will target exosomes, bubbles of protein and RNA molecules excreted by cancerous cells that can block immune system cells from fighting the illness. By removing exosomes from circulating blood, Aethlon officials hope their device will improve the body's ability to fight cancer and the effectiveness of treatments such as chemotherapy. Blood taken from 25 patients with non-small cell lung cancer, prostate cancer, melanoma, sarcoma, and head and neck cancer will be circulated through the Hemopurifier device. In clinical use, blood would be filltered directly from the patient and returned to the body in a similar way to kidney dialysis. However, in the newly announced pre-clinical trial blood will not be returned to patients, Aethlon Chairman and Chief Executive Officer James Joyce said. "if we validate that our Hemopurifier is efficient in capturing exosomes, its possible that we could transition towards a human treatment study to evaluate exosome clearance from the entire circulatory system," he said. The test will be conducted by the Sarcoma Oncology Center, a nonprofit independent research institute focused on cancer therapy development. "This clinical histological study is a critical validation step in Aethlon's Hemopurifier strategy for cancer," said Dr. Sant Chawla, the trial's chief investigator. "The concept of 'subtractive therapy', eliminating a major mechanism of tumor progression and resistance to drugs, [...]

Students can’t commit to quitting

Source: www.gcsunade.com Author: Lindsay Peterson A Georgia College student steps outside, pauses and inhales, filling his lungs with acetone, ammonia, arsenic, benzene, butane, formaldehyde, lead and turpentine – just 8 of the more than 50 carcinogens found in the average cigarette. According to the Centers for Disease Control and Prevention, of the 46 million smokers in the U.S., college students are among the highest percentage of smokers. Almost 22 percent of adults ages 18-24 smoke, according to 2009 CDC data. Their professors are not far behind them in their smoking addiction. According to the CDC data, almost 22 percent of people ages 45-64 are smokers. In 2009, the CDC found that adults in the Southeast were among the most prevalent smokers in the United States. While there are no hard statistics for the percentage of students and staff that smoke at GC, it is not uncommon to see a familiar gathering of smokers sitting outside any of the dorms. Lauren Luker, junior mass communication major, started smoking in order to get a break at her job as a server. “You couldn’t have a break unless it was a smoke break,” Luker said. Now, eight years later, Luker is worried about the health of her lungs and is planning on quitting after several previous failed attempts. However, quitting such an addictive habit is not always easy, as Luker knows. According to the National Institute on Drug Abuse, nicotine is as addictive as heroin and cocaine. Fortunately for GC students and staff [...]

George Karl takes cancer message to fundraiser in Spokane

Source: www.nba.com Author: Aaron J. Lopez, Nuggets.com Nuggets coach George Karl will be the first person to admit that his fashion sense is more faux pas than je ne sais quoi. He prefers shorts and golf shirts over dress shoes and designer ties, and he often jokes that his clothing choice for the day is determined by what’s on top of the hamper. When it comes to assisting in the fight against cancer, Karl will meet even the strictest of dress codes. Karl, who has survived head and neck cancer and prostate cancer in the past six years, will don a tuxedo this weekend when he serves as the guest speaker at a Coaches vs. Cancer fundraiser in Spokane, Wash. It is the 10th year of the event founded by Gonzaga men’s basketball coach Mark Few and his wife Marcy. “I enjoy speaking about cancer,” Karl said. “It’s become my hobby/ambassadorship, whatever word you want to use. I play amateur sociologist and try to help people become more aware about what is going on.” Karl, 60, has become extremely educated about cancer treatments, research and funding options since recovering from his latest battle over the past 20 months. He is a spokesman for the Cancer Care Initiative at Swedish Medical Center in Englewood and St. Jude Research Hospital in Memphis, Tenn. He also is active with the Cancer League of Colorado and the American Cancer Society. “With all the information and knowledge we have our hands on now, it seems [...]

New Study for Cancer Patients to Help Improve the Body’s Ability to Fight Illness

Source: Sign On San Diego A Santa Monica research center will test an experimental therapeutic filtering device being developed by Aethlon Medical on blood taken from cancer patients, the San Diego company said Wednesday. The study will target exosomes, bubbles of protein and RNA molecules excreted by cancerous cells that can block immune system cells from fighting the illness. By removing exosomes from circulating blood, Aethlon officials hope their device will improve the body's ability to fight cancer and the effectiveness of treatments such as chemotherapy. Blood taken from 25 patients with non-small cell lung cancer, prostate cancer, melanoma, sarcoma, and head and neck cancer will be circulated through the Hemopurifier device. In clinical use, blood would be filltered directly from the patient and returned to the body in a similar way to kidney dialysis. However, in the newly announced pre-clinical trial blood will not be returned to patients, Aethlon Chairman and Chief Executive Officer James Joyce said. "If we validate that our Hemopurifier is efficient in capturing exosomes, its possible that we could transition towards a human treatment study to evaluate exosome clearance from the entire circulatory system," he said. The test will be conducted by the Sarcoma Oncology Center, a nonprofit independent research institute focused on cancer therapy development. "This clinical histological study is a critical validation step in Aethlon's Hemopurifier strategy for cancer," said Dr. Sant Chawla, the trial's chief investigator. "The concept of 'subtractive therapy', eliminating a major mechanism of tumor progression and resistance to drugs, [...]

Songwriter Nick Ashford Dies; Had Throat Cancer

Source: The New York Times Nick Ashford, who with Valerie Simpson, his songwriting partner and later wife, wrote some of Motown’s biggest hits, like “Ain’t No Mountain High Enough“ and “Ain’t Nothing Like the Real Thing,” and later recorded their own hits and toured as a duo, died Monday at a hospital in New York City. He was 70 and lived in Manhattan. Mr. Ashford had throat cancer and was undergoing treatment, but the cause of his death was not immediately known. His death was announced by Liz Rosenberg, a friend who is a longtime music publicist. One of the primary songwriting and producing teams of Motown, Ashford & Simpson specialized in romantic duets of the most dramatic kind, professing the power of true love and the comforts of sweet talk. In “Ain’t No Mountain High Enough,” from 1967, their first of several hits for Marvin Gaye and Tammi Terrell, lovers in close harmony proclaim their determination that “no wind, no rain, no winter’s cold, can stop me, baby,” but also make cuter promises: “If you’re ever in trouble, I’ll be there on the double.” Gaye and Terrell also sang the duo’s songs “Your Precious Love,” “Ain’t Nothing Like the Real Thing” and “You’re All I Need to Get By.” Diana Ross sang their “Reach Out and Touch Somebody’s Hand,” and when she rerecorded “Ain’t No Mountain High Enough“ in 1970, it became the former Supreme’s first No. 1 hit as a solo artist. “They had magic, and that’s what [...]

Using mouthwash can increase cancer risk for smokers

Source: www.independent.ie Author: Eilish O’Regan, health correspondent Smokers have been warned to stay away from mouthwash – as it might increase their risk of developing mouth cancer. The combination of smoking and drinking alcohol has been established as increasing the risk of the disease. Now researchers have warned that may apply even to the alcohol contained in mouthwash. They pointed out that, while the link between the use of mouthwash containing alcohol and the cancer is not firmly established, it is best avoided or limited in use by smokers. The risk was examined by researchers led by dentist Dr John Reidy and colleagues in the Royal College of Surgeons and St James’s Hospital in Dublin. Around 400 new cases of oral cancer are diagnosed each year in Ireland with two people a week dying from the disease. Symptoms include red and white patches on the lining of the mouth or tongue, a mouth ulcer that does not heal or a swelling that lasts for more than three weeks. The most effective way of preventing mouth cancer is to quit smoking and limit consumption of alcohol, say experts. The researchers said they were concerned about the effects the alcohol in the mouthwash had and it was therefore “prudent” to restrict its use by smokers who are considered “high-risk” for mouth cancer. Around three-quarters of mouth cancers arise due to a patient both smoking and drinking, according to the study in the Journal of the Irish Dental Association. -

Chicago Blackhawks legend Stan Makita optimistic regardless of having mouth cancer

Source: blogs.bettor.com Author: staff Chicago Blackhawks legendary centre player, Stan Mikita, was diagnosed with stage 1 of oral cancer in May of this year, a shocking revelation the former player made through the National Hockey League (NHL) franchise, but luckily, it has termed to be not life-threatening. Since his diagnosis, Mikita, also a Hall of Famer expressed that recently he is beginning to feel much better about the situation and explains it as something which has not hampered his day-to-day activities. He still does everything in his usual manner, something that is more than he could have asked for at the age of 71. “I will know in 10 days how my recovery is when I see the doctor”, Mikita said at the Blackhawks Alumni golf outing named for him at Medinah Country Club. “I’m looking for very favorable comments from him. I might need some work done probably, but I hope it’s not forever. It’s been coming along real well”. Mikita played all 22 seasons of his career in one of the most loyal ways and that was with Chicago Blackhawks. It all began after he was picked up for his performance in the St. Catharines Teepees in the Junior Ontario Hockey Association. He played his first three games during the 1958-1959 season and went on all the way till 1979-1980. Fans who see him in this condition cannot help but ask about the progression. "The best part is, (they ask) 'Are you on skates yet'?" Mikita said, smiling. [...]

Oral epithelial dysplasia: What does it really mean?

Source: www.rdhmag.com Author: Nancy W. Burkhart, RDH, EdD Patients are sometimes followed for periods of time for what is called dysplasia, leukoplakia, keratotic lesions, and previous frank carcinoma. With any degree of tissue change, the person should be followed closely and an etiology always needs to be determined. Sometimes, removal of a frictional component is suggested; at other times, the lesion may have a more ominous appearance that will alert the clinician that cancer might be high on the differential list. Obviously, in highly suspicious lesions, a biopsy would occur immediately. Patients will sometimes tell the clinician that they were previously biopsied and the report will note "evidence of dysplasia." Sometimes a diagnosis is made of dysplasia, but the lesion becomes carcinoma over time, even after the initial removal of the lesion. The reverse may be true as well, where the body responds physically and the tissue regains a state of health. Why does one individual develop carcinoma while another person may develop a mild epithelial dysplasia? Perhaps the body is able to stop progression or reverse the state of progression. These are questions that researchers continue to evaluate and study. Frictional keratosis, though, is not in the same category as dysplasia. When the frictional component is removed, the lesion will subside. An example of a common lesion that has a frictional component is cheek chewing or morsicatio buccarum. However, chronic frictional or chemical assault on the tissue over time can also cause dysplastic changes. The body has [...]

Dental Care Denied by Medicare Turns into Major Lawsuit

Source: Dr.Bicuspid.com Medicare's refusal to cover extensive dental treatment that is often needed to treat patients with diseases such as oral cancer and Sjögren's syndrome is unreasonable and arbitrary, according to a lawsuit pending in U.S. federal court. The litigation, originally filed in 2008 on behalf of one plaintiff, was recently amended by the Center for Medicare Advocacy (CMA) in the U.S. District Court for the District of Arizona against U.S. Health and Human Services Secretary Kathleen Sebelius on behalf of three Medicare beneficiaries who needed medically related dental care stemming from underlying medical conditions. Medicare policy, which excludes coverage of "routine" dental care, does cover dental services when they are "incident to and an integral part of" eligible medical care. Dental procedures that are covered include extractions in preparation of radiation treatment of neoplastic disease, reconstruction of ridges that are performed simultaneously with the surgical removal of oral tumors, and the wiring of teeth if done in connection with jaw fractures. "We have argued that this is a misinterpretation of the Medicare statute," said CMA attorney Sally Hart, who filed the suit. "We think that beneficiaries who require extensive dental services because of damage from Sjögren's syndrome, as well as cancer radiation treatment and other conditions that destroy the production of saliva, should not fall within the exclusion." CMS does not comment on pending litigation, CMS spokesman Tony Salters told DrBicuspid.com. Why coverage denied Each of the plaintiffs in the CMA lawsuit suffered a serious medical condition, resulting in [...]

Asparagus as antimicrobial agent in oral cancer infections

Source: www.insidecosmeceuticals.com Author: staff According to Indian researchers, treated oral cancer patients are neutropenic and prone to secondary infection of microbes, and medicinal plants such as asparagus may serve as effective antimicrobial agents to check the secondary infections in treated oral cancer patients (Ann Clin Microbiol Antimicrob. 2011;10:21). Suppression of immune system in treated cancer patients may lead to secondary infections that obviate the need of antibiotics. In the present study, an attempt was made to understand the occurrence of secondary infections in immunosuppressed patients along with herbal control of these infections with the following objectives to: (a) isolate the microbial species from the treated oral cancer patients along with the estimation of absolute neutrophile counts of patients (b) assess the in vitro antimicrobial activity medicinal plants against the above clinical isolates. Blood and oral swab cultures were taken from 40 oral cancer patients undergoing treatment in the radiotherapy unit of Regional Cancer Institute, Pt. B.D.S. Health University,Rohtak, Haryana. Clinical isolates were identified by following general microbiological, staining and biochemical methods. The absolute neutrophile counts were done by following the standard methods. The medicinal plants selected for antimicrobial activity analysis were Asphodelus tenuifolius Cav., Asparagus racemosus Willd., Balanites aegyptiaca L., Cestrum diurnum L., Cordia dichotoma G. Forst, Eclipta alba L., Murraya koenigii (L.) Spreng. , Pedalium murex L., Ricinus communis L. and Trigonella foenum graecum L. Prevalent bacterial pathogens isolated were Staphylococcus aureus (23.2 percent), Escherichia coli (15.62 percent), Staphylococcus epidermidis (12.5 percent), Pseudomonas aeruginosa (9.37 percent), Klebsiella pneumonia (7.81 [...]

Go to Top